LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
SBUX
Starbucks Corporation
SBUX has the edge over LCID overall, supported by lower modeled downside and stronger modeled upside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SBUX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
SBUX's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SBUX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $54.72 | -49% |
| Fair | 32x | $71.35 | -33% |
| Forward | 33x | $107 | — |
| Current | 49x | $107 | — |
| Expensive | 78x | $172 | +60% |
Historical ranges are pointers, not guarantees.
SBUX's PE is in its expensive range at 49x. If earnings grow as analysts expect, today's price would be 33x next year's earnings, in its fair range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SBUX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect SBUX's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
SBUX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.23 | +46% |
| Q3 2026 | $2.21 | +36% |
| Q2 2026 | $1.73 | -25% |
| Q1 2026 | $1.31 | -53% |
| Q4 2025 | $1.20 | -61% |
| Q3 2025 | $1.63 | -51% |
| Q2 2025 | $2.32 | -35% |
| Q1 2025 | $2.76 | -24% |
| Q4 2024 | $3.10 | -17% |
SBUX has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SBUX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SBUX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.1B | -4.5% |
| Q2 2026 | $9.3B | -1.4% |
| Q1 2026 | $9.5B | +8.8% |
| Q4 2025 | $9.9B | +5.5% |
| Q3 2025 | $9.6B | +5.5% |
| Q2 2025 | $9.5B | +3.8% |
| Q1 2025 | $8.8B | +2.3% |
| Q4 2024 | $9.4B | -0.3% |
SBUX's revenue grew through 2023 and has held roughly level since: $9.1B last quarter, down 4.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +7.9 points |
| Q2 2026 | 11% | +0.6 points |
| Q1 2026 | 8.7% | +1.8 points |
| Q4 2025 | 9% | -3 points |
| Q3 2025 | 2.9% | -12 points |
| Q2 2025 | 9.9% | -6.8 points |
| Q1 2025 | 6.9% | -6 points |
| Q4 2024 | 12% | -3.8 points |
SBUX has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SBUX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1B | +8.9% |
| Q2 2026 | $1.4B | +211% |
| Q1 2026 | $91.8M | +$389M |
| Q4 2025 | $1.3B | -7.6% |
| Q3 2025 | $925.8M | +26% |
| Q2 2025 | $434.3M | -54% |
| Q1 2025 | -$297.2M | -$144.1M |
| Q4 2024 | $1.4B | -23% |
SBUX has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SBUX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -400K shares |
| 1 year | +0.3% | +3.6M shares |
| 3 years | -0.7% | -7.9M shares |
| 5 years | -3.6% | -42.1M shares |
| Available history | -4% | -47.6M shares |
SBUX has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | $1.3B |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SBUX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.9x | Moderate |
| Q3 2025 | 2.8x | Moderate |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 1.8x | Healthy |
SBUX's net debt is about 1.8 years of its operating earnings (EBITDA), down from 2.8 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SBUX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.1 | Neutral |
| Stochastic | 75.9 | Neutral |
SBUX's weekly RSI is 59 (neutral) and its Stochastic is 76 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SBUX PE vs Consumer Cyclical Sector
| Metric | SBUX | Sector median | Relative |
|---|---|---|---|
| PE | 49x | 18x | 169% above |
| PE % | 70 | 47 | 23 pts above |
SBUX is trading at 49x earnings, a 169% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SBUX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $99.4 | 7.9% above |
| 20 week MA | $102.3 | 4.8% above |
| 50 week MA | $98.4 | 9% above |
| 100 week MA | $94.8 | 13% above |
| 200 week MA | $94.9 | 13% above |
SBUX has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SBUX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $88.1 | $102.0 | +16% |
| 2021 | $102.0 | $112.4 | +10% |
| 2022 | $112.4 | $98.3 | -13% |
| 2023 | $98.3 | $96.0 | -2.3% |
| 2024 | $96.0 | $92.3 | -3.9% |
| 2025 | $92.3 | $85.1 | -7.8% |
| 2026 YTD | $85.1 | $107.3 | +26% |
SBUX has the edge over LCID on returns for 2026, with the stronger performance.